Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Kocaeli University80 enrolled

Overview

bmı \> 35 morbidly obese patients requiring endotracheal intubation enrolled in this trial. Divided into two groups Airtraq and ILMA. their effectiveness is evaluated.

80 patients, 18-65 years of aged ASA I-III, BMI\> 35 patients enrolled in this trial. Divided into two groups ; Airtraq and ILMA . BMI\>35, upper airway tumour , respiratory infection less than ten days, excluded from this study. patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade. The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

Conditions

Intubation; Difficult or Failed Intubation Complication

Interventions

AirtraqDEVICE

video laryngoscope with a channel

ILMADEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria:18-65 years of age * ASA I-III * BMI\>35 Exclusion Criteria:BMI\<35 * patients have airway tumor * patients undergoing head and neck surgery * upper respiratory infection less than 10 days prior the surgery

Locations (1)

Kocaeli University School of Medicine

Kocaeli, Turkey (Türkiye)

Outcomes

Primary Outcomes

intubation time

handling of the device till the endotracheal tube entering the glottis

Time frame: 1 minute

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.